Mao et al. [19] showed that SIRT1 increases the interaction between YAP2 and TEAD4 and enhances resistance to the anti-cancer drug cisplatin by deacetylating YAP2 in HCC cells. The gene discussed is TEAD4; the disease is hepatocellular carcinoma.